Table 3 Overview of WBV utilization on physical performance status
Go-Go | Slow-Go | No-Go | |||
|---|---|---|---|---|---|
VS-WBV | VS-WBV | ||||
1 | Amaral et al. [78] (SA) FS | 1 | Alvarez et al. [62] FS | ||
2 | Beck et al. [35] FS | 2 | Bautmans [34] DS, Power, RFD | ||
3 | Boegarts et al. [37] IMVC, RFD | 3 | Boegarts et al. [36] IMVC | ||
4 | Boegarts et al. [38] IMVC | 4 | Corrie et al. [6] Power, FS, RFD | ||
5 | Gomez-Cabello et al. [42] FS | 5 | Sitja-Rabert et al. [68] FS | ||
6 | Kemmler et al. [44] IMVC, Power, | 6 | Verscheuern et al. [57] IMVC, DS | ||
7 | RFD | ||||
8 | Kennis et al. [45] IMVC, DS, RFD | ||||
9 | Klarner et al. [46] IMVC, RFD | ||||
10 | Lachane [47] FS | ||||
11 | Leung et al. [66] IMVC | ||||
12 | Machado et al. [48] MVC, Power | ||||
13 | Mikhael et al. [49] DS, Power, FS | ||||
14 | Roelants et al. [53] IMVC, DS, RFD | ||||
15 | Verscheuren et al. [58] IMVC, DS | ||||
SS-WBV | SS-WBV | SS-WBV | |||
1 | Beck et al. [35] FS | 1 | Calder et al. [39] FS | 1 | Sievänen et al. [61] FS |
2 | Furness and Maschette [40] FS | 2 | Corrie et al. [65] Power, RFD, FS | 2 | Zhang et al. [60] IMVC, FS |
3 | Furness et al. [41] FS | 3 | Ochi et al. [67] IMVC | ||
4 | Iwamoto et al. [43] FS | ||||
5 | Klarner et al. [46] IMVC, RFD | ||||
6 | Raimundo et al. [50] DS, Power, RFD; FS | ||||
7 | Rees et al. [51] DS, FS | ||||
8 | Rees et al. [52] DS, Power | ||||
9 | Russo et al. [55] DS, RFD | ||||
10 | Stolzenberg et al. [56] Power, RFD, FS | ||||
11 | von Stengel et al. [59] IMVC, RFD | ||||
SR-WBV | SR-WBV | ||||
1 | 1 | Rogan et al. [54] FS | 1 | Kessler et al. [23] IMVC, RFD, FS | |
2 | 2 | Rogan et al. [20] IMVC, IRFD, FS | |||
SMD 0.26 (95 % CI 0.15 to 0.63) | SMD of 0.14 (95 % CI −0.04 to 0.33) | SMD of 0.47 (95 % CI 0.16 to 0.78) | |||
I2 48.9 %, p <0.001 | I2 26.6 %, p = 0.121 | I2 0.00 %, p <0.792 |